1. University of Lausanne, Institute of Microbiology and University Hospital, Bugnon 48 – CHUV,1011 Lausanne, Switzerland.
2. University of Lausanne, Institute of Microbiology and University Hospital, Bugnon 48 – CHUV,1011 Lausanne, Switzerland and GlaxoSmithKline, Infectious Diseases Medicines Development Center, Greenford, UK